buspirone has been researched along with Amphetamine-Related Disorders in 2 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Amphetamine-Related Disorders: Disorders related or resulting from use of amphetamines.
Excerpt | Relevance | Reference |
---|---|---|
"Buspirone is a dopamine autoreceptor and D3 receptor antagonist and partial agonist at serotonin 1A receptors, making it a logical candidate medication for methamphetamine-use disorder." | 2.84 | Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine. ( Lile, JA; Reynolds, AR; Rush, CR; Stoops, WW; Strickland, JC, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Reynolds, AR | 1 |
Strickland, JC | 1 |
Stoops, WW | 1 |
Lile, JA | 1 |
Rush, CR | 1 |
Paterson, NE | 1 |
Vocci, F | 1 |
Sevak, RJ | 1 |
Wagreich, E | 1 |
London, ED | 1 |
1 review available for buspirone and Amphetamine-Related Disorders
Article | Year |
---|---|
Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.
Topics: Amphetamine-Related Disorders; Animals; Behavior, Addictive; Buspirone; Cardiovascular System; Dopam | 2014 |
1 trial available for buspirone and Amphetamine-Related Disorders
Article | Year |
---|---|
Buspirone maintenance does not alter the reinforcing, subjective, and cardiovascular effects of intranasal methamphetamine.
Topics: Administration, Intranasal; Adult; Amphetamine-Related Disorders; Buspirone; Cardiovascular System; | 2017 |